Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of VHL polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ti |
More info about VHL polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB12546 |
| Product name: | VHL polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of VHL. |
| Gene id: | 7428|22346 |
| Gene name: | VHL |
| Gene alias: | HRCA1|RCA1|VHL1 |
| Gene description: | von Hippel-Lindau tumor suppressor |
| Immunogen: | A synthetic peptide corresponding to human and mouse VHL/Vhl. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:500-1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human,Mouse |
| Specificity: | This antibody is specific to VHL protein. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of VHL in human kidney samples (30 ug) using VHL polyclonal antibody (Cat # PAB12546). Lane 1 : 0.5 ug/mL primary. Lane 2 : 2 ug/mL primary. |
| Applications: | WB-Ti |
| Shipping condition: | Blue Ice |
| Publications: | Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.Esteban MA, Tran MG, Harten SK, Hill P, Castellanos MC, Chandra A, Raval R, O'brien TS, Maxwell PH. Cancer Res. 2006 Apr 1;66(7):3567-75. |